BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 24409667)

  • 1. The relationship between ischemia modified albumin and oxidative stress parameters in patients with cardiac syndrome X.
    Demir B; Ozyazgan S; Korkmaz GG; Karakaya O; Aciksari G; Uygun T; Onal B; Uzun H
    Clin Lab; 2013; 59(11-12):1319-29. PubMed ID: 24409667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ischemia-modified albumin and advanced oxidation protein products as potential biomarkers of protein oxidation in Alzheimer's disease.
    Altunoglu E; Guntas G; Erdenen F; Akkaya E; Topac I; Irmak H; Derici H; Yavuzer H; Gelisgen R; Uzun H
    Geriatr Gerontol Int; 2015 Jul; 15(7):872-80. PubMed ID: 25345484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [N-terminal pro-brain natriuretic peptide (NT-proBNP) and ischemia modified albumin (IMA) in exercise induced ischemia in patients with stable coronary artery disease].
    Piechota WN; Wierzbowski R; Piechota WT; Bejm J; Gielerak G
    Pol Arch Med Wewn; 2006 Jul; 116(1):640-7. PubMed ID: 17340970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-reactive protein, clinical presentation, and ischemic activity in patients with chest pain and normal coronary angiograms.
    Cosín-Sales J; Pizzi C; Brown S; Kaski JC
    J Am Coll Cardiol; 2003 May; 41(9):1468-74. PubMed ID: 12742283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total antioxidant status and markers of oxidative stress in subjects with normal or impaired glucose regulation (IFG, IGT) in diabetic patients.
    Korkmaz GG; Konukoglu D; Kurtulus EM; Irmak H; Bolayirli M; Uzun H
    Scand J Clin Lab Invest; 2013 Dec; 73(8):641-9. PubMed ID: 24152132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation of protein oxidation parameters and disease activity in patients with Behçet's disease.
    Ozyazgan S; Andican G; Erman H; Tuzcu A; Uzun H; Onal B; Ozyazgan Y
    Clin Lab; 2013; 59(7-8):819-25. PubMed ID: 24133911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of oxidative stress in the evaluation of acute pulmonary embolism severity.
    Sagcan G; Konukoglu D; Uzun H; Arseven O; Okumus G; Cuhadaroglu C
    BMC Pulm Med; 2022 Oct; 22(1):382. PubMed ID: 36253755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The serum pentraxin-3 is elevated in patients with cardiac syndrome X.
    Büyükkaya E; Karakaş MF; Kurt M; Motor S; Akçay AB; Büyükkaya S; Karakaş E; Sen N
    Turk Kardiyol Dern Ars; 2013 Jun; 41(4):290-5. PubMed ID: 23760115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further evidence of inflammation in chronic rheumatic valve disease (CRVD): high levels of advanced oxidation protein products (AOPP) and high sensitive C-reactive protein (hs-CRP).
    Chiu-Braga YY; Hayashi SY; Schafranski M; Messias-Reason IJ
    Int J Cardiol; 2006 May; 109(2):275-6. PubMed ID: 15946754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ischemia-modified albumin and total antioxidant status in patients with slow coronary flow: a pilot observational study.
    Koç F; Erdem S; Altunkaş F; Ozbek K; Gül EE; Kurban S; Taşyürek E; Erbay E; Söğüt E
    Anadolu Kardiyol Derg; 2011 Nov; 11(7):582-7. PubMed ID: 21911320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The evaluation of oxidative stress parameters in breast and colon cancer.
    Kundaktepe BP; Sozer V; Durmus S; Kocael PC; Kundaktepe FO; Papila C; Gelisgen R; Uzun H
    Medicine (Baltimore); 2021 Mar; 100(11):e25104. PubMed ID: 33725987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association of oxidative stress markers with conventional risk factors in the metabolic syndrome.
    Korkmaz GG; Altınoglu E; Civelek S; Sozer V; Erdenen F; Tabak O; Uzun H
    Metabolism; 2013 Jun; 62(6):828-35. PubMed ID: 23410746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the usefulness of plasma levels of oxidatively modified forms of albumin in estimating kidney dysfunction in diabetic patients.
    Piwowar A; Knapik-Kordecka M; Warwas M
    Clin Invest Med; 2010 Apr; 33(2):E109. PubMed ID: 20370990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of serum gamma-glutamyltransferase levels between patients with cardiac syndrome X and healthy asymptomatic individuals.
    Demir B; Temizhan A; Keskin G; Baser K; Turak O; Cay S
    Kardiol Pol; 2012; 70(1):31-7. PubMed ID: 22267422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidatively modified forms of albumin in patients with risk factors of metabolic syndrome.
    Zurawska-Płaksej E; Grzebyk E; Marciniak D; Szymańska-Chabowska A; Piwowar A
    J Endocrinol Invest; 2014 Sep; 37(9):819-27. PubMed ID: 24957167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of fluoxetine on circulating oxidative damage parameters in rats exposed to aortic ischemia-reperfusion.
    Erman H; Guner I; Yaman MO; Uzun DD; Gelisgen R; Aksu U; Yelmen N; Sahin G; Uzun H
    Eur J Pharmacol; 2015 Feb; 749():56-61. PubMed ID: 25595729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between serum uric acid, high sensitive C-reactive protein and pro-oxidant-antioxidant balance in patients with metabolic syndrome.
    Ahmadnezhad M; Arefhosseini SR; Parizadeh MR; Tavallaie S; Tayefi M; Darroudi S; Ghazizadeh H; Moohebati M; Ebrahimi M; Heidari-Bakavoli A; Azarpajouh MR; Ferns GA; Mogharebzadeh V; Ghayour-Mobarhan M
    Biofactors; 2018 May; 44(3):263-271. PubMed ID: 29638023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of thiol levels, thiol/disulfide homeostasis and their relation with inflammation in cardiac syndrome X.
    Altiparmak IH; Erkus ME; Sezen H; Demirbag R; Kaya Z; Sezen Y; Gunebakmaz O; Asoglu R; Besli F; Neselioglu S; Erel O
    Coron Artery Dis; 2016 Jun; 27(4):295-301. PubMed ID: 26928883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in oxidative stress parameters and antioxidant status in lung cancer: Western blot analysis of nitrotyrosine and protein carbonyls content.
    Korkmaz GG; Inal BB; Ortakoylu GM; Irmak H; Kara AA; Gelisgen R; Ogurlu O; Uzun H
    Clin Lab; 2014; 60(4):599-607. PubMed ID: 24779293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics of Ischemia-Modified Albumin Following Exercise-Induced Myocardial Ischemia.
    Bakula M; Milicevic G; Bakula M; Kozic I; Rumenjak V; Dominkovic A
    Clin Lab; 2016; 62(4):563-71. PubMed ID: 27215074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.